Morepen Laboratories Limited
NSE:MOREPENLAB.NS
83.34 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 14,139.55 | 14,175.3 | 15,415.65 | 11,753.673 | 8,396.026 | 7,562.144 | 5,977.529 | 5,839.02 | 4,850.804 | 4,006.4 | 3,668.5 | 3,259.2 | 2,893.4 | 2,293.36 | 2,121.833 | 1,854.77 | 1,477.671 | 1,707.908 |
| Cost of Revenue
| 9,703.73 | 9,557.444 | 10,609.373 | 7,867.766 | 5,619.517 | 4,988.607 | 3,696.976 | 3,736.354 | 2,996.873 | 2,455.1 | 2,151.6 | 1,991.6 | 1,834.1 | 1,949.318 | 1,817.9 | 1,612.981 | 1,255.792 | 1,336.582 |
| Gross Profit
| 4,435.82 | 4,617.856 | 4,806.277 | 3,885.907 | 2,776.509 | 2,573.537 | 2,280.553 | 2,102.666 | 1,853.931 | 1,551.3 | 1,516.9 | 1,267.6 | 1,059.3 | 344.042 | 303.933 | 241.789 | 221.879 | 371.326 |
| Gross Profit Ratio
| 0.314 | 0.326 | 0.312 | 0.331 | 0.331 | 0.34 | 0.382 | 0.36 | 0.382 | 0.387 | 0.413 | 0.389 | 0.366 | 0.15 | 0.143 | 0.13 | 0.15 | 0.217 |
| Reseach & Development Expenses
| 30.69 | 30.689 | 30.082 | 56.461 | 25.469 | 9.586 | 5.042 | 4.14 | 4.65 | 3.15 | 3.8 | 4.8 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,357.771 | 141.622 | 141.85 | 121.705 | 145.525 | 152.908 | 95.437 | 70.764 | 0 | 0 | 31.2 | 23.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 1,099.789 | 930.136 | 535.799 | 496.567 | 401.101 | 327.322 | 300.368 | 353.831 | 0 | 0 | 195.5 | 204 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2,457.56 | 930.136 | 677.649 | 618.272 | 546.626 | 480.23 | 395.805 | 424.595 | 512.436 | 516.847 | 807.3 | 738.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 139.708 | 61.334 | 89.774 | 99.346 | 52.873 | 28.495 | 36.022 | 1,371.986 | 1,580.091 | 1,447.7 | 1,484.6 | 1,402.4 | 1,347.4 | 757.697 | 35.659 | 20.112 | 100.359 | 59.926 |
| Operating Expenses
| 3,919.8 | 4,101.829 | 3,715.98 | 3,003.598 | 2,460.423 | 2,297.388 | 1,976.498 | 1,796.581 | 1,580.091 | 1,447.7 | 1,484.6 | 1,402.4 | 1,347.4 | 757.697 | 669.266 | 715.103 | 799.155 | 794.604 |
| Operating Income
| 516.03 | 560.787 | 1,180.072 | 981.654 | 369.015 | 304.7 | 304.055 | 306.085 | 273.84 | 103.6 | 32.3 | -134.8 | -288.1 | -413.655 | -365.333 | -473.314 | -577.276 | -423.278 |
| Operating Income Ratio
| 0.036 | 0.04 | 0.077 | 0.084 | 0.044 | 0.04 | 0.051 | 0.052 | 0.056 | 0.026 | 0.009 | -0.041 | -0.1 | -0.18 | -0.172 | -0.255 | -0.391 | -0.248 |
| Total Other Income Expenses Net
| 41.53 | -3.234 | 86.954 | 3.461 | 22.061 | -12.933 | -6.346 | -70.752 | -147.197 | -80.8 | -59.7 | -70.4 | 52.4 | -62.659 | 302.918 | 60.322 | 31.029 | -907.406 |
| Income Before Tax
| 557.55 | 557.553 | 1,267.026 | 985.115 | 391.076 | 291.767 | 297.709 | 235.333 | 126.643 | 22.8 | -27.4 | -205.2 | -235.7 | -476.314 | -62.415 | -412.992 | -546.247 | -1,330.684 |
| Income Before Tax Ratio
| 0.039 | 0.039 | 0.082 | 0.084 | 0.047 | 0.039 | 0.05 | 0.04 | 0.026 | 0.006 | -0.007 | -0.063 | -0.081 | -0.208 | -0.029 | -0.223 | -0.37 | -0.779 |
| Income Tax Expense
| 170.8 | 170.798 | 250.213 | 14.215 | 55.287 | 3.363 | 34.147 | 0.785 | -1.347 | 1.4 | 0.1 | 0.05 | 0.6 | -6.839 | 0.268 | 6.301 | 2.379 | 255.887 |
| Net Income
| 386.75 | 386.752 | 1,016.827 | 970.859 | 335.792 | 288.493 | 295.914 | 235.378 | 127.997 | 21.4 | -27.7 | -205.2 | -236.5 | -469.443 | -62.17 | -417.584 | -548.644 | -1,584.593 |
| Net Income Ratio
| 0.027 | 0.027 | 0.066 | 0.083 | 0.04 | 0.038 | 0.05 | 0.04 | 0.026 | 0.005 | -0.008 | -0.063 | -0.082 | -0.205 | -0.029 | -0.225 | -0.371 | -0.928 |
| EPS
| 0.77 | 0.77 | 2.26 | 2.16 | 0.75 | 0.64 | 0.66 | 0.53 | 0.28 | 0.04 | -0.062 | -0.46 | -0.53 | -1.04 | -0.15 | -1.17 | -2.16 | -7.51 |
| EPS Diluted
| 0.77 | 0.77 | 1.96 | 2.15 | 0.75 | 0.64 | 0.66 | 0.53 | 0.28 | 0.04 | -0.062 | -0.46 | -0.53 | -1.04 | -0.15 | -1.17 | -2.16 | -7.51 |
| EBITDA
| 1,586.246 | 856.665 | 1,567.712 | 1,300.938 | 775.089 | 706.933 | 679.627 | 645.956 | 627.638 | 496.1 | 501.2 | 332 | 204.1 | 67.898 | 114.873 | 48.066 | -9.658 | 174.552 |
| EBITDA Ratio
| 0.112 | 0.06 | 0.102 | 0.111 | 0.092 | 0.093 | 0.114 | 0.111 | 0.129 | 0.124 | 0.137 | 0.102 | 0.071 | 0.03 | 0.054 | 0.026 | -0.007 | 0.102 |